CLINICAL SIGNIFICANCE OF N-TERMINAL FRAGMENT OF NATRIURETIC PEPTIDE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO DO NOT RECEIVE PATHOGENETIC THERAPY

T. A. Panafidina, M. A. Sokhova, T. V. Popkova, D. S. Novikova, E. N. Aleksandrova, Yu. O. Korsakova, A. V. Volkov

Open source

DOI
10.14412/1995-4484-2017-376-381
Published
2017-09-29
Container
Rheumatology Science and Practice
Publisher
Mediar Press
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14412/1995-4484-2017-376-381,
  title = {CLINICAL SIGNIFICANCE OF N-TERMINAL FRAGMENT OF NATRIURETIC PEPTIDE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO DO NOT RECEIVE PATHOGENETIC THERAPY},
  author = {T. A. Panafidina and M. A. Sokhova and T. V. Popkova and D. S. Novikova and E. N. Aleksandrova and Yu. O. Korsakova and A. V. Volkov},
  year = {2017},
  journal = {Rheumatology Science and Practice},
  doi = {10.14412/1995-4484-2017-376-381},
  url = {https://doi.org/10.14412/1995-4484-2017-376-381}
}

RIS

TY  - JOUR
TI  - CLINICAL SIGNIFICANCE OF N-TERMINAL FRAGMENT OF NATRIURETIC PEPTIDE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO DO NOT RECEIVE PATHOGENETIC THERAPY
AU  - T. A. Panafidina
AU  - M. A. Sokhova
AU  - T. V. Popkova
AU  - D. S. Novikova
AU  - E. N. Aleksandrova
AU  - Yu. O. Korsakova
AU  - A. V. Volkov
PY  - 2017
JO  - Rheumatology Science and Practice
DO  - 10.14412/1995-4484-2017-376-381
UR  - https://doi.org/10.14412/1995-4484-2017-376-381
ER  - 

APA

Panafidina, T. A., Sokhova, M. A., Popkova, T. V., Novikova, D. S., Aleksandrova, E. N., Korsakova, Y. O., & Volkov, A. V. (2017). CLINICAL SIGNIFICANCE OF N-TERMINAL FRAGMENT OF NATRIURETIC PEPTIDE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO DO NOT RECEIVE PATHOGENETIC THERAPY. Rheumatology Science and Practice. https://doi.org/10.14412/1995-4484-2017-376-381

Source records